Turn Therapeutics TTRX
NASDAQ TTRX
$10.58 +0.11 (+1.05%)
As of: Oct 21, 2026 · 2:06 PM EDT

Turn Therapeutics (TTRX) Operating Leases (2024 - 2026)

Updated

Turn Therapeutics' Operating Leases was $8,713 in Q2 2026, down 59.5% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Operating Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, Operating Leases at Turn Therapeutics came in at $34,081, down 57.6% from FY2024.

  • In earlier years, Operating Leases was $80,376 in FY2024.
  • Per Business Quant data, TTRX's Operating Leases in the three quarters before Q2 2026 was $21,539 (Q1 2026), $34,081 (Q4 2025) and $46,344 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.90 Bn 1,102.48 Bn 19.71 Bn
2 Johnson & Johnson 616.46 Bn 534.99 Bn 17.26 Bn
3 AbbVie 501.26 Bn 474.37 Bn 12.70 Bn
4 Merck 367.00 Bn 321.38 Bn 12.21 Bn
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 235.82 Bn 191.22 Bn 7.24 Bn
8 Gilead Sciences 190.63 Bn 164.82 Bn 6.22 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn
10 Turn Therapeutics 315.16 Mn 288.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8,713.00
Mar 31, 2026 21,539.00
Dec 31, 2025 34,081.00
Sep 30, 2025 46,344.00
Dec 31, 2024 80,376.00
API Access

Turn Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=TTRX&period=max&api_key=YOUR_API_KEY